Osteomesopyknosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2777OMIM:166450Q78.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Osteomesopyknosis is an extremely rare inherited bone disorder characterized by abnormally increased bone density (osteosclerosis) that predominantly affects the axial skeleton, specifically the vertebral bodies and pelvis. Unlike many other sclerosing bone dysplasias, osteomesopyknosis typically spares the appendicular skeleton (limbs) and the skull. The condition was first described in the 1980s and derives its name from the Greek roots referring to bone (osteo), middle (meso), and dense (pyknos), reflecting the increased density seen primarily in the central or axial portions of the skeleton. The hallmark radiographic finding is a characteristic pattern of dense sclerosis of the vertebral bodies, particularly affecting the thoracic and lumbar spine, along with the pelvic bones. The sclerosis tends to involve the central portions of the vertebral bodies while relatively sparing the peripheral areas. Most affected individuals are identified incidentally on radiographs taken for other reasons, such as back pain, though the relationship between the skeletal findings and symptoms like back pain remains uncertain. Many patients may be asymptomatic, and the condition is generally considered benign. Osteomesopyknosis follows an autosomal dominant inheritance pattern, meaning that a single copy of the altered gene from one affected parent is sufficient to cause the condition. The specific genetic basis has not been fully elucidated. There is no specific treatment for osteomesopyknosis, as the condition is typically benign and does not lead to significant complications such as fractures, bone marrow failure, or cranial nerve compression, which can be seen in other sclerosing bone disorders. Management is generally supportive, with monitoring and symptomatic treatment of any associated back pain if present.

Also known as:

Clinical phenotype terms— hover any for plain English:

Increased bone mineral densityHP:0011001Sclerotic vertebral bodyHP:0100861
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Osteomesopyknosis.

View clinical trials →

No actively recruiting trials found for Osteomesopyknosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Osteomesopyknosis community →

No specialists are currently listed for Osteomesopyknosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Osteomesopyknosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OsteomesopyknosisForum →

No community posts yet. Be the first to share your experience with Osteomesopyknosis.

Start the conversation →

Latest news about Osteomesopyknosis

No recent news articles for Osteomesopyknosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Osteomesopyknosis

What is Osteomesopyknosis?

Osteomesopyknosis is an extremely rare inherited bone disorder characterized by abnormally increased bone density (osteosclerosis) that predominantly affects the axial skeleton, specifically the vertebral bodies and pelvis. Unlike many other sclerosing bone dysplasias, osteomesopyknosis typically spares the appendicular skeleton (limbs) and the skull. The condition was first described in the 1980s and derives its name from the Greek roots referring to bone (osteo), middle (meso), and dense (pyknos), reflecting the increased density seen primarily in the central or axial portions of the skeleto

How is Osteomesopyknosis inherited?

Osteomesopyknosis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.